免疫サイトカインの世界市場インサイト、2030年までの予測Global Immunocytokines Market Insights, Forecast to 2030 イムノサイトカイン(IC)は、腫瘍に反応するモノクローナル抗体を免疫細胞を活性化するサイトカインに結合させることによって作られる分子の一種である。 世界のイムノサイトカイン市場は、2024年の100万米ドル... もっと見る
※当ページの内容はウェブ更新時の情報です。
サマリーイムノサイトカイン(IC)は、腫瘍に反応するモノクローナル抗体を免疫細胞を活性化するサイトカインに結合させることによって作られる分子の一種である。世界のイムノサイトカイン市場は、2024年の100万米ドルから2030年には100万米ドルへと、予測期間中の年平均成長率(CAGR)%で拡大すると予測されている。 米国とカナダの免疫サイトカイン市場は、2025年から2030年の予測期間中にCAGR%で、2024年の百万米ドルから2030年には百万米ドルに達すると予測されています。 免疫サイトカインの中国市場は、2024年の100万ドルから2030年には100万ドルに達すると推定され、2025年から2030年の予測期間中のCAGRは%である。 イムノサイトカインのヨーロッパ市場は、2024年の100万ドルから2030年には100万ドルに達すると推定され、2025年から2030年の予測期間中のCAGRは%である。 免疫細胞薬の世界の主要メーカーには、Alkermes Plc、AstraZeneca Plc、CytImmune、Cytune Pharma、Altor Biosciences Corporation、Apeiron Biologics AG、Paladin Labs、Teva Pharmaceutical Industries Ltd.、Valor Biotherapeuticsなどがある。2023年、世界の上位5社の売上高シェアは約 %であった。 レポートの対象 本レポートでは、イムノサイトカインの世界市場の概要、売上高、収益、価格を紹介しています。2019年~2023年の過去の市場収益/売上データ、2024年の予測、2030年までのCAGR予測による世界市場動向の分析。 免疫サイトカインの主要生産者を調査し、主要地域・国の売上高も掲載しています。免疫細胞薬の今後の市場ポテンシャルと、この市場を様々なセグメントとサブセグメントに分けて予測するための主要地域/国の注目点をハイライトしています。米国、カナダ、メキシコ、ブラジル、中国、日本、韓国、東南アジア、インド、ドイツ、英国、イタリア、中東、アフリカ、その他の国々の国別データと市場価値分析。 本レポートでは、2019年から2024年までのデータで、免疫サイトカインの売上高、収益、市場シェア、主要メーカーの業界ランキングに焦点を当てています。世界の免疫サイトカイン市場における主要なステークホルダーを特定し、その競争環境と市場ポジショニングを最近の動向とセグメント別の収益に基づいて分析します。本レポートは、利害関係者が競争環境を理解し、より多くの洞察を得て、より良い方法で事業と市場戦略を位置づけるのに役立ちます。 本レポートでは、2019年から2030年までのセグメントデータをタイプ別、用途別、売上高、収益、価格で分析しています。免疫サイトカインの売上高、予測成長動向、生産技術、用途、エンドユーザー産業の市場規模を評価・予測します。 市場区分 企業別 アルカーメス アストラゼネカ サイチューン サイトューン・ファーマ アルトール・バイオサイエンシズ株式会社 アペイロン・バイオロジクス パラディン・ラボ テバ・ファーマシューティカル・インダストリーズ ヴァロー・バイオセラピューティクス タルガ・セラピューティクス株式会社 イムノメディクス社 イムンジーン社 モルメッドS.p.A. メルクKGaA ネクター・セラピューティクス ファイザー F.ホフマン・ラ・ロシュ社 タイプ別セグメント 肝臓 視床下部 脂肪筋 BおよびTリンパ球 骨髄内皮 用途別セグメント 腫瘍および癌 関節リウマチ 地域別セグメント 米国およびカナダ 米国 カナダ 中国 アジア(中国を除く) 日本 韓国 中国 台湾 東南アジア インド ヨーロッパ ドイツ フランス 英国 イタリア ロシア ラテンアメリカ、中東、アフリカ ブラジル メキシコ トルコ イスラエル GCC諸国 各章の概要 第1章:報告書のスコープ、各市場セグメント(タイプ別、用途別など)の市場規模、今後の発展可能性などのエグゼクティブサマリーを紹介。市場の現状と、短期・中期・長期的な展開の可能性について、ハイレベルな見解を提供しています。 第2章 世界、地域レベル、国レベルでの免疫サイトカインの販売(消費)、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展見通し、市場スペース、生産能力などを紹介しています。 第3章:免疫サイトカインメーカーの競争環境、価格、売上高、市場シェア、業界ランキング、最新の開発計画、M&A情報などを詳細に分析。 第4章:各種市場セグメントをタイプ別に分析し、各市場セグメントの売上高、収益、平均価格、発展可能性などを網羅し、読者が各市場セグメントのブルーオーシャン市場を見つけやすくします。 第5章:用途別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展可能性をカバーし、読者が異なる下流市場のブルーオーシャン市場を見つけるのを助ける。 第6章 北米(米国・カナダ):タイプ別、用途別、国別、セグメント別の売上高、収益。 第7章:ヨーロッパ:タイプ別、用途別、国別、セグメント別の売上高、収益。 第8章:中国:タイプ別、用途別、セグメント別の売上高、収益。 第9章:アジア(中国を除く):タイプ別、用途別、地域別、セグメント別の売上高、収益。 第10章:中東、アフリカ、中南米:タイプ別、用途別、国別、セグメント別の売上高、収益。 第11章:主要メーカーのプロファイルを提供し、製品の説明と仕様、免疫サイトカインの売上高、収益、価格、粗利益率、最近の開発など、市場の主要企業の基本的な状況を詳細に紹介する。 第12章:産業チェーン、販売チャネル、主要原材料、流通業者、顧客の分析。 第13章:市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界のメーカーが直面する課題とリスク、業界の関連政策の分析を紹介します。 第14章:レポートの要点と結論。 目次1 Study Coverage1.1 Immunocytokines Product Introduction 1.2 Market by Type 1.2.1 Global Immunocytokines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 1.2.2 Liver 1.2.3 Hypothalamus 1.2.4 Fat muscle 1.2.5 B and T lymphocytes 1.2.6 Bone Marrow Endothelium 1.3 Market by Application 1.3.1 Global Immunocytokines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 1.3.2 Tumors and Cancer 1.3.3 Rheumatoid Arthritis 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Executive Summary 2.1 Global Immunocytokines Sales Estimates and Forecasts 2019-2030 2.2 Global Immunocytokines Revenue by Region 2.2.1 Global Immunocytokines Revenue by Region: 2019 VS 2023 VS 2030 2.2.2 Global Immunocytokines Revenue by Region (2019-2024) 2.2.3 Global Immunocytokines Revenue by Region (2025-2030) 2.2.4 Global Immunocytokines Revenue Market Share by Region (2019-2030) 2.3 Global Immunocytokines Sales Estimates and Forecasts 2019-2030 2.4 Global Immunocytokines Sales by Region 2.4.1 Global Immunocytokines Sales by Region: 2019 VS 2023 VS 2030 2.4.2 Global Immunocytokines Sales by Region (2019-2024) 2.4.3 Global Immunocytokines Sales by Region (2025-2030) 2.4.4 Global Immunocytokines Sales Market Share by Region (2019-2030) 2.5 US & Canada 2.6 Europe 2.7 China 2.8 Asia (excluding China) 2.9 Middle East, Africa and Latin America 3 Competition by Manufactures 3.1 Global Immunocytokines Sales by Manufacturers 3.1.1 Global Immunocytokines Sales by Manufacturers (2019-2024) 3.1.2 Global Immunocytokines Sales Market Share by Manufacturers (2019-2024) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Immunocytokines in 2023 3.2 Global Immunocytokines Revenue by Manufacturers 3.2.1 Global Immunocytokines Revenue by Manufacturers (2019-2024) 3.2.2 Global Immunocytokines Revenue Market Share by Manufacturers (2019-2024) 3.2.3 Global Top 10 and Top 5 Companies by Immunocytokines Revenue in 2023 3.3 Global Key Players of Immunocytokines, Industry Ranking, 2022 VS 2023 VS 2024 3.4 Global Immunocytokines Sales Price by Manufacturers 3.5 Analysis of Competitive Landscape 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.5.2 Global Immunocytokines Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.6 Global Key Manufacturers of Immunocytokines, Manufacturing Base Distribution and Headquarters 3.7 Global Key Manufacturers of Immunocytokines, Product Offered and Application 3.8 Global Key Manufacturers of Immunocytokines, Date of Enter into This Industry 3.9 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Immunocytokines Sales by Type 4.1.1 Global Immunocytokines Historical Sales by Type (2019-2024) 4.1.2 Global Immunocytokines Forecasted Sales by Type (2025-2030) 4.1.3 Global Immunocytokines Sales Market Share by Type (2019-2030) 4.2 Global Immunocytokines Revenue by Type 4.2.1 Global Immunocytokines Historical Revenue by Type (2019-2024) 4.2.2 Global Immunocytokines Forecasted Revenue by Type (2025-2030) 4.2.3 Global Immunocytokines Revenue Market Share by Type (2019-2030) 4.3 Global Immunocytokines Price by Type 4.3.1 Global Immunocytokines Price by Type (2019-2024) 4.3.2 Global Immunocytokines Price Forecast by Type (2025-2030) 5 Market Size by Application 5.1 Global Immunocytokines Sales by Application 5.1.1 Global Immunocytokines Historical Sales by Application (2019-2024) 5.1.2 Global Immunocytokines Forecasted Sales by Application (2025-2030) 5.1.3 Global Immunocytokines Sales Market Share by Application (2019-2030) 5.2 Global Immunocytokines Revenue by Application 5.2.1 Global Immunocytokines Historical Revenue by Application (2019-2024) 5.2.2 Global Immunocytokines Forecasted Revenue by Application (2025-2030) 5.2.3 Global Immunocytokines Revenue Market Share by Application (2019-2030) 5.3 Global Immunocytokines Price by Application 5.3.1 Global Immunocytokines Price by Application (2019-2024) 5.3.2 Global Immunocytokines Price Forecast by Application (2025-2030) 6 US & Canada 6.1 US & Canada Immunocytokines Market Size by Type 6.1.1 US & Canada Immunocytokines Sales by Type (2019-2030) 6.1.2 US & Canada Immunocytokines Revenue by Type (2019-2030) 6.2 US & Canada Immunocytokines Market Size by Application 6.2.1 US & Canada Immunocytokines Sales by Application (2019-2030) 6.2.2 US & Canada Immunocytokines Revenue by Application (2019-2030) 6.3 US & Canada Immunocytokines Market Size by Country 6.3.1 US & Canada Immunocytokines Revenue by Country: 2019 VS 2023 VS 2030 6.3.2 US & Canada Immunocytokines Sales by Country (2019-2030) 6.3.3 US & Canada Immunocytokines Revenue by Country (2019-2030) 6.3.4 US 6.3.5 Canada 7 Europe 7.1 Europe Immunocytokines Market Size by Type 7.1.1 Europe Immunocytokines Sales by Type (2019-2030) 7.1.2 Europe Immunocytokines Revenue by Type (2019-2030) 7.2 Europe Immunocytokines Market Size by Application 7.2.1 Europe Immunocytokines Sales by Application (2019-2030) 7.2.2 Europe Immunocytokines Revenue by Application (2019-2030) 7.3 Europe Immunocytokines Market Size by Country 7.3.1 Europe Immunocytokines Revenue by Country: 2019 VS 2023 VS 2030 7.3.2 Europe Immunocytokines Sales by Country (2019-2030) 7.3.3 Europe Immunocytokines Revenue by Country (2019-2030) 7.3.4 Germany 7.3.5 France 7.3.6 U.K. 7.3.7 Italy 7.3.8 Russia 8 China 8.1 China Immunocytokines Market Size 8.1.1 China Immunocytokines Sales (2019-2030) 8.1.2 China Immunocytokines Revenue (2019-2030) 8.2 China Immunocytokines Market Size by Application 8.2.1 China Immunocytokines Sales by Application (2019-2030) 8.2.2 China Immunocytokines Revenue by Application (2019-2030) 9 Asia (excluding China) 9.1 Asia Immunocytokines Market Size by Type 9.1.1 Asia Immunocytokines Sales by Type (2019-2030) 9.1.2 Asia Immunocytokines Revenue by Type (2019-2030) 9.2 Asia Immunocytokines Market Size by Application 9.2.1 Asia Immunocytokines Sales by Application (2019-2030) 9.2.2 Asia Immunocytokines Revenue by Application (2019-2030) 9.3 Asia Immunocytokines Sales by Region 9.3.1 Asia Immunocytokines Revenue by Region: 2019 VS 2023 VS 2030 9.3.2 Asia Immunocytokines Revenue by Region (2019-2030) 9.3.3 Asia Immunocytokines Sales by Region (2019-2030) 9.3.4 Japan 9.3.5 South Korea 9.3.6 China Taiwan 9.3.7 Southeast Asia 9.3.8 India 10 Middle East, Africa and Latin America 10.1 Middle East, Africa and Latin America Immunocytokines Market Size by Type 10.1.1 Middle East, Africa and Latin America Immunocytokines Sales by Type (2019-2030) 10.1.2 Middle East, Africa and Latin America Immunocytokines Revenue by Type (2019-2030) 10.2 Middle East, Africa and Latin America Immunocytokines Market Size by Application 10.2.1 Middle East, Africa and Latin America Immunocytokines Sales by Application (2019-2030) 10.2.2 Middle East, Africa and Latin America Immunocytokines Revenue by Application (2019-2030) 10.3 Middle East, Africa and Latin America Immunocytokines Sales by Country 10.3.1 Middle East, Africa and Latin America Immunocytokines Revenue by Country: 2019 VS 2023 VS 2030 10.3.2 Middle East, Africa and Latin America Immunocytokines Revenue by Country (2019-2030) 10.3.3 Middle East, Africa and Latin America Immunocytokines Sales by Country (2019-2030) 10.3.4 Brazil 10.3.5 Mexico 10.3.6 Turkey 10.3.7 Israel 10.3.8 GCC Countries 11 Company Profiles 11.1 Alkermes Plc 11.1.1 Alkermes Plc Company Information 11.1.2 Alkermes Plc Overview 11.1.3 Alkermes Plc Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024) 11.1.4 Alkermes Plc Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Alkermes Plc Recent Developments 11.2 AstraZeneca Plc 11.2.1 AstraZeneca Plc Company Information 11.2.2 AstraZeneca Plc Overview 11.2.3 AstraZeneca Plc Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024) 11.2.4 AstraZeneca Plc Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 AstraZeneca Plc Recent Developments 11.3 CytImmune 11.3.1 CytImmune Company Information 11.3.2 CytImmune Overview 11.3.3 CytImmune Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024) 11.3.4 CytImmune Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 CytImmune Recent Developments 11.4 Cytune Pharma 11.4.1 Cytune Pharma Company Information 11.4.2 Cytune Pharma Overview 11.4.3 Cytune Pharma Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024) 11.4.4 Cytune Pharma Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Cytune Pharma Recent Developments 11.5 Altor Biosciences Corporation 11.5.1 Altor Biosciences Corporation Company Information 11.5.2 Altor Biosciences Corporation Overview 11.5.3 Altor Biosciences Corporation Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024) 11.5.4 Altor Biosciences Corporation Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Altor Biosciences Corporation Recent Developments 11.6 Apeiron Biologics AG 11.6.1 Apeiron Biologics AG Company Information 11.6.2 Apeiron Biologics AG Overview 11.6.3 Apeiron Biologics AG Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024) 11.6.4 Apeiron Biologics AG Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Apeiron Biologics AG Recent Developments 11.7 Paladin Labs 11.7.1 Paladin Labs Company Information 11.7.2 Paladin Labs Overview 11.7.3 Paladin Labs Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024) 11.7.4 Paladin Labs Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 Paladin Labs Recent Developments 11.8 Teva Pharmaceutical Industries Ltd. 11.8.1 Teva Pharmaceutical Industries Ltd. Company Information 11.8.2 Teva Pharmaceutical Industries Ltd. Overview 11.8.3 Teva Pharmaceutical Industries Ltd. Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024) 11.8.4 Teva Pharmaceutical Industries Ltd. Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 Teva Pharmaceutical Industries Ltd. Recent Developments 11.9 Valor Biotherapeutics 11.9.1 Valor Biotherapeutics Company Information 11.9.2 Valor Biotherapeutics Overview 11.9.3 Valor Biotherapeutics Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024) 11.9.4 Valor Biotherapeutics Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 Valor Biotherapeutics Recent Developments 11.10 Targa Therapeutics Corporation 11.10.1 Targa Therapeutics Corporation Company Information 11.10.2 Targa Therapeutics Corporation Overview 11.10.3 Targa Therapeutics Corporation Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024) 11.10.4 Targa Therapeutics Corporation Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications 11.10.5 Targa Therapeutics Corporation Recent Developments 11.11 Immunomedics, Inc. 11.11.1 Immunomedics, Inc. Company Information 11.11.2 Immunomedics, Inc. Overview 11.11.3 Immunomedics, Inc. Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024) 11.11.4 Immunomedics, Inc. Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications 11.11.5 Immunomedics, Inc. Recent Developments 11.12 ImmunGene, Inc. 11.12.1 ImmunGene, Inc. Company Information 11.12.2 ImmunGene, Inc. Overview 11.12.3 ImmunGene, Inc. Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024) 11.12.4 ImmunGene, Inc. Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications 11.12.5 ImmunGene, Inc. Recent Developments 11.13 MolMed S.p.A. 11.13.1 MolMed S.p.A. Company Information 11.13.2 MolMed S.p.A. Overview 11.13.3 MolMed S.p.A. Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024) 11.13.4 MolMed S.p.A. Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications 11.13.5 MolMed S.p.A. Recent Developments 11.14 Merck KGaA 11.14.1 Merck KGaA Company Information 11.14.2 Merck KGaA Overview 11.14.3 Merck KGaA Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024) 11.14.4 Merck KGaA Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications 11.14.5 Merck KGaA Recent Developments 11.15 Nektar Therapeutics 11.15.1 Nektar Therapeutics Company Information 11.15.2 Nektar Therapeutics Overview 11.15.3 Nektar Therapeutics Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024) 11.15.4 Nektar Therapeutics Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications 11.15.5 Nektar Therapeutics Recent Developments 11.16 Pfizer, Inc. 11.16.1 Pfizer, Inc. Company Information 11.16.2 Pfizer, Inc. Overview 11.16.3 Pfizer, Inc. Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024) 11.16.4 Pfizer, Inc. Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications 11.16.5 Pfizer, Inc. Recent Developments 11.17 F. Hoffmann-La Roche, Ltd. 11.17.1 F. Hoffmann-La Roche, Ltd. Company Information 11.17.2 F. Hoffmann-La Roche, Ltd. Overview 11.17.3 F. Hoffmann-La Roche, Ltd. Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024) 11.17.4 F. Hoffmann-La Roche, Ltd. Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications 11.17.5 F. Hoffmann-La Roche, Ltd. Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Immunocytokines Industry Chain Analysis 12.2 Immunocytokines Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Immunocytokines Production Mode & Process 12.4 Immunocytokines Sales and Marketing 12.4.1 Immunocytokines Sales Channels 12.4.2 Immunocytokines Distributors 12.5 Immunocytokines Customers 13 Market Dynamics 13.1 Immunocytokines Industry Trends 13.2 Immunocytokines Market Drivers 13.3 Immunocytokines Market Challenges 13.4 Immunocytokines Market Restraints 14 Key Findings in The Global Immunocytokines Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer
SummaryImmunocytokines (ICs) are a class of molecules created by linking tumor-reactive monoclonal antibodies to cytokines that are able to activate immune cells. Table of Contents1 Study Coverage1.1 Immunocytokines Product Introduction 1.2 Market by Type 1.2.1 Global Immunocytokines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 1.2.2 Liver 1.2.3 Hypothalamus 1.2.4 Fat muscle 1.2.5 B and T lymphocytes 1.2.6 Bone Marrow Endothelium 1.3 Market by Application 1.3.1 Global Immunocytokines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 1.3.2 Tumors and Cancer 1.3.3 Rheumatoid Arthritis 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Executive Summary 2.1 Global Immunocytokines Sales Estimates and Forecasts 2019-2030 2.2 Global Immunocytokines Revenue by Region 2.2.1 Global Immunocytokines Revenue by Region: 2019 VS 2023 VS 2030 2.2.2 Global Immunocytokines Revenue by Region (2019-2024) 2.2.3 Global Immunocytokines Revenue by Region (2025-2030) 2.2.4 Global Immunocytokines Revenue Market Share by Region (2019-2030) 2.3 Global Immunocytokines Sales Estimates and Forecasts 2019-2030 2.4 Global Immunocytokines Sales by Region 2.4.1 Global Immunocytokines Sales by Region: 2019 VS 2023 VS 2030 2.4.2 Global Immunocytokines Sales by Region (2019-2024) 2.4.3 Global Immunocytokines Sales by Region (2025-2030) 2.4.4 Global Immunocytokines Sales Market Share by Region (2019-2030) 2.5 US & Canada 2.6 Europe 2.7 China 2.8 Asia (excluding China) 2.9 Middle East, Africa and Latin America 3 Competition by Manufactures 3.1 Global Immunocytokines Sales by Manufacturers 3.1.1 Global Immunocytokines Sales by Manufacturers (2019-2024) 3.1.2 Global Immunocytokines Sales Market Share by Manufacturers (2019-2024) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Immunocytokines in 2023 3.2 Global Immunocytokines Revenue by Manufacturers 3.2.1 Global Immunocytokines Revenue by Manufacturers (2019-2024) 3.2.2 Global Immunocytokines Revenue Market Share by Manufacturers (2019-2024) 3.2.3 Global Top 10 and Top 5 Companies by Immunocytokines Revenue in 2023 3.3 Global Key Players of Immunocytokines, Industry Ranking, 2022 VS 2023 VS 2024 3.4 Global Immunocytokines Sales Price by Manufacturers 3.5 Analysis of Competitive Landscape 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.5.2 Global Immunocytokines Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.6 Global Key Manufacturers of Immunocytokines, Manufacturing Base Distribution and Headquarters 3.7 Global Key Manufacturers of Immunocytokines, Product Offered and Application 3.8 Global Key Manufacturers of Immunocytokines, Date of Enter into This Industry 3.9 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Immunocytokines Sales by Type 4.1.1 Global Immunocytokines Historical Sales by Type (2019-2024) 4.1.2 Global Immunocytokines Forecasted Sales by Type (2025-2030) 4.1.3 Global Immunocytokines Sales Market Share by Type (2019-2030) 4.2 Global Immunocytokines Revenue by Type 4.2.1 Global Immunocytokines Historical Revenue by Type (2019-2024) 4.2.2 Global Immunocytokines Forecasted Revenue by Type (2025-2030) 4.2.3 Global Immunocytokines Revenue Market Share by Type (2019-2030) 4.3 Global Immunocytokines Price by Type 4.3.1 Global Immunocytokines Price by Type (2019-2024) 4.3.2 Global Immunocytokines Price Forecast by Type (2025-2030) 5 Market Size by Application 5.1 Global Immunocytokines Sales by Application 5.1.1 Global Immunocytokines Historical Sales by Application (2019-2024) 5.1.2 Global Immunocytokines Forecasted Sales by Application (2025-2030) 5.1.3 Global Immunocytokines Sales Market Share by Application (2019-2030) 5.2 Global Immunocytokines Revenue by Application 5.2.1 Global Immunocytokines Historical Revenue by Application (2019-2024) 5.2.2 Global Immunocytokines Forecasted Revenue by Application (2025-2030) 5.2.3 Global Immunocytokines Revenue Market Share by Application (2019-2030) 5.3 Global Immunocytokines Price by Application 5.3.1 Global Immunocytokines Price by Application (2019-2024) 5.3.2 Global Immunocytokines Price Forecast by Application (2025-2030) 6 US & Canada 6.1 US & Canada Immunocytokines Market Size by Type 6.1.1 US & Canada Immunocytokines Sales by Type (2019-2030) 6.1.2 US & Canada Immunocytokines Revenue by Type (2019-2030) 6.2 US & Canada Immunocytokines Market Size by Application 6.2.1 US & Canada Immunocytokines Sales by Application (2019-2030) 6.2.2 US & Canada Immunocytokines Revenue by Application (2019-2030) 6.3 US & Canada Immunocytokines Market Size by Country 6.3.1 US & Canada Immunocytokines Revenue by Country: 2019 VS 2023 VS 2030 6.3.2 US & Canada Immunocytokines Sales by Country (2019-2030) 6.3.3 US & Canada Immunocytokines Revenue by Country (2019-2030) 6.3.4 US 6.3.5 Canada 7 Europe 7.1 Europe Immunocytokines Market Size by Type 7.1.1 Europe Immunocytokines Sales by Type (2019-2030) 7.1.2 Europe Immunocytokines Revenue by Type (2019-2030) 7.2 Europe Immunocytokines Market Size by Application 7.2.1 Europe Immunocytokines Sales by Application (2019-2030) 7.2.2 Europe Immunocytokines Revenue by Application (2019-2030) 7.3 Europe Immunocytokines Market Size by Country 7.3.1 Europe Immunocytokines Revenue by Country: 2019 VS 2023 VS 2030 7.3.2 Europe Immunocytokines Sales by Country (2019-2030) 7.3.3 Europe Immunocytokines Revenue by Country (2019-2030) 7.3.4 Germany 7.3.5 France 7.3.6 U.K. 7.3.7 Italy 7.3.8 Russia 8 China 8.1 China Immunocytokines Market Size 8.1.1 China Immunocytokines Sales (2019-2030) 8.1.2 China Immunocytokines Revenue (2019-2030) 8.2 China Immunocytokines Market Size by Application 8.2.1 China Immunocytokines Sales by Application (2019-2030) 8.2.2 China Immunocytokines Revenue by Application (2019-2030) 9 Asia (excluding China) 9.1 Asia Immunocytokines Market Size by Type 9.1.1 Asia Immunocytokines Sales by Type (2019-2030) 9.1.2 Asia Immunocytokines Revenue by Type (2019-2030) 9.2 Asia Immunocytokines Market Size by Application 9.2.1 Asia Immunocytokines Sales by Application (2019-2030) 9.2.2 Asia Immunocytokines Revenue by Application (2019-2030) 9.3 Asia Immunocytokines Sales by Region 9.3.1 Asia Immunocytokines Revenue by Region: 2019 VS 2023 VS 2030 9.3.2 Asia Immunocytokines Revenue by Region (2019-2030) 9.3.3 Asia Immunocytokines Sales by Region (2019-2030) 9.3.4 Japan 9.3.5 South Korea 9.3.6 China Taiwan 9.3.7 Southeast Asia 9.3.8 India 10 Middle East, Africa and Latin America 10.1 Middle East, Africa and Latin America Immunocytokines Market Size by Type 10.1.1 Middle East, Africa and Latin America Immunocytokines Sales by Type (2019-2030) 10.1.2 Middle East, Africa and Latin America Immunocytokines Revenue by Type (2019-2030) 10.2 Middle East, Africa and Latin America Immunocytokines Market Size by Application 10.2.1 Middle East, Africa and Latin America Immunocytokines Sales by Application (2019-2030) 10.2.2 Middle East, Africa and Latin America Immunocytokines Revenue by Application (2019-2030) 10.3 Middle East, Africa and Latin America Immunocytokines Sales by Country 10.3.1 Middle East, Africa and Latin America Immunocytokines Revenue by Country: 2019 VS 2023 VS 2030 10.3.2 Middle East, Africa and Latin America Immunocytokines Revenue by Country (2019-2030) 10.3.3 Middle East, Africa and Latin America Immunocytokines Sales by Country (2019-2030) 10.3.4 Brazil 10.3.5 Mexico 10.3.6 Turkey 10.3.7 Israel 10.3.8 GCC Countries 11 Company Profiles 11.1 Alkermes Plc 11.1.1 Alkermes Plc Company Information 11.1.2 Alkermes Plc Overview 11.1.3 Alkermes Plc Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024) 11.1.4 Alkermes Plc Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Alkermes Plc Recent Developments 11.2 AstraZeneca Plc 11.2.1 AstraZeneca Plc Company Information 11.2.2 AstraZeneca Plc Overview 11.2.3 AstraZeneca Plc Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024) 11.2.4 AstraZeneca Plc Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 AstraZeneca Plc Recent Developments 11.3 CytImmune 11.3.1 CytImmune Company Information 11.3.2 CytImmune Overview 11.3.3 CytImmune Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024) 11.3.4 CytImmune Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 CytImmune Recent Developments 11.4 Cytune Pharma 11.4.1 Cytune Pharma Company Information 11.4.2 Cytune Pharma Overview 11.4.3 Cytune Pharma Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024) 11.4.4 Cytune Pharma Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Cytune Pharma Recent Developments 11.5 Altor Biosciences Corporation 11.5.1 Altor Biosciences Corporation Company Information 11.5.2 Altor Biosciences Corporation Overview 11.5.3 Altor Biosciences Corporation Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024) 11.5.4 Altor Biosciences Corporation Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Altor Biosciences Corporation Recent Developments 11.6 Apeiron Biologics AG 11.6.1 Apeiron Biologics AG Company Information 11.6.2 Apeiron Biologics AG Overview 11.6.3 Apeiron Biologics AG Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024) 11.6.4 Apeiron Biologics AG Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Apeiron Biologics AG Recent Developments 11.7 Paladin Labs 11.7.1 Paladin Labs Company Information 11.7.2 Paladin Labs Overview 11.7.3 Paladin Labs Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024) 11.7.4 Paladin Labs Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 Paladin Labs Recent Developments 11.8 Teva Pharmaceutical Industries Ltd. 11.8.1 Teva Pharmaceutical Industries Ltd. Company Information 11.8.2 Teva Pharmaceutical Industries Ltd. Overview 11.8.3 Teva Pharmaceutical Industries Ltd. Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024) 11.8.4 Teva Pharmaceutical Industries Ltd. Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 Teva Pharmaceutical Industries Ltd. Recent Developments 11.9 Valor Biotherapeutics 11.9.1 Valor Biotherapeutics Company Information 11.9.2 Valor Biotherapeutics Overview 11.9.3 Valor Biotherapeutics Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024) 11.9.4 Valor Biotherapeutics Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 Valor Biotherapeutics Recent Developments 11.10 Targa Therapeutics Corporation 11.10.1 Targa Therapeutics Corporation Company Information 11.10.2 Targa Therapeutics Corporation Overview 11.10.3 Targa Therapeutics Corporation Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024) 11.10.4 Targa Therapeutics Corporation Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications 11.10.5 Targa Therapeutics Corporation Recent Developments 11.11 Immunomedics, Inc. 11.11.1 Immunomedics, Inc. Company Information 11.11.2 Immunomedics, Inc. Overview 11.11.3 Immunomedics, Inc. Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024) 11.11.4 Immunomedics, Inc. Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications 11.11.5 Immunomedics, Inc. Recent Developments 11.12 ImmunGene, Inc. 11.12.1 ImmunGene, Inc. Company Information 11.12.2 ImmunGene, Inc. Overview 11.12.3 ImmunGene, Inc. Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024) 11.12.4 ImmunGene, Inc. Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications 11.12.5 ImmunGene, Inc. Recent Developments 11.13 MolMed S.p.A. 11.13.1 MolMed S.p.A. Company Information 11.13.2 MolMed S.p.A. Overview 11.13.3 MolMed S.p.A. Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024) 11.13.4 MolMed S.p.A. Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications 11.13.5 MolMed S.p.A. Recent Developments 11.14 Merck KGaA 11.14.1 Merck KGaA Company Information 11.14.2 Merck KGaA Overview 11.14.3 Merck KGaA Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024) 11.14.4 Merck KGaA Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications 11.14.5 Merck KGaA Recent Developments 11.15 Nektar Therapeutics 11.15.1 Nektar Therapeutics Company Information 11.15.2 Nektar Therapeutics Overview 11.15.3 Nektar Therapeutics Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024) 11.15.4 Nektar Therapeutics Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications 11.15.5 Nektar Therapeutics Recent Developments 11.16 Pfizer, Inc. 11.16.1 Pfizer, Inc. Company Information 11.16.2 Pfizer, Inc. Overview 11.16.3 Pfizer, Inc. Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024) 11.16.4 Pfizer, Inc. Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications 11.16.5 Pfizer, Inc. Recent Developments 11.17 F. Hoffmann-La Roche, Ltd. 11.17.1 F. Hoffmann-La Roche, Ltd. Company Information 11.17.2 F. Hoffmann-La Roche, Ltd. Overview 11.17.3 F. Hoffmann-La Roche, Ltd. Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024) 11.17.4 F. Hoffmann-La Roche, Ltd. Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications 11.17.5 F. Hoffmann-La Roche, Ltd. Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Immunocytokines Industry Chain Analysis 12.2 Immunocytokines Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Immunocytokines Production Mode & Process 12.4 Immunocytokines Sales and Marketing 12.4.1 Immunocytokines Sales Channels 12.4.2 Immunocytokines Distributors 12.5 Immunocytokines Customers 13 Market Dynamics 13.1 Immunocytokines Industry Trends 13.2 Immunocytokines Market Drivers 13.3 Immunocytokines Market Challenges 13.4 Immunocytokines Market Restraints 14 Key Findings in The Global Immunocytokines Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療/ヘルスケア)の最新刊レポート
QYResearch社の医薬・ヘルスケア分野での最新刊レポート
本レポートと同じKEY WORD()の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/14 10:27 156.77 円 166.04 円 201.95 円 |